NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
AI Kidney Disease Detection: Transforming Eye Screenings for Diabetic Patients
Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Addressing Physical Inactivity in MENA and Beyond
Global Diabetes Trends and Treatment Gaps: 1990-2022 Analysis
Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy
Diabetes Diagnosis through Retinal Imaging and Deep Learning
Rising Diabetes Prevalence in the Middle East and North Africa
Diabetes Crisis in South Africa: Prevalence, Impact, and Solutions